WEKO3
アイテム
{"_buckets": {"deposit": "05c58f36-7e41-4923-96cb-be01b3067b2c"}, "_deposit": {"created_by": 1, "id": "60486", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "60486"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00060486", "sets": ["29"]}, "author_link": ["600473", "600469", "600474", "600471", "600472", "600475", "600470"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2004-07-11", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The toxicities and effects of CBMIDA and EHBP on removal of depleted uranium (DU) by intramuscular injection in the femoral muscles as simulated wounds in rats were examined in Experiment I~III. Male rats, 8 weeks old, were used. Experiment I: Rats were injected intramuscularly with 7.9, 15,8, 31.5, 63 and 126mg/kg depleted uranium. All rats died from 3~7 days after injection. The concentrations of DU in the kidneys were 8.4-16.6% of injected doses (r=0.997). In the rats injected with 63, 126 mg/kg, the urinary excretion of DU was observed at first day, and the feces excretion was for 2 days, but did not observed at third day. Total amount of excreted DU for 3 days were 3.4 % and 4.9% of the injected doses. \n Experiment II: Rats were injected with 63 mg/kg DU, and then killed 1, 3, 6 and 24 hours to know the retention. The concentration of DU decreased rapidly in the serum, while increased in the kidneys and liver until 6 hours after injection, and continued to increase in the femur until 24 hours. \n Experiment III: Forty rats were injected intramuscularly with 2mg/kg DU, and divide into four groups; G1) non-treated, G2) 0.48mg/kg CBMIDA, G3) 0.24mg/kg CBMIDA, and G4) 10mg/kg EHBP. The chelating agents were administered intraperitoneally once everyday for 28 days. Rats died for firs 10 days in the G1~3, and for 14 days in the G4. The survival rates at the end of experiment were 20% in the G1, 40% in the G2, 80% in the G3 and 50% in the G4. The rapid decreases in body weights were observed for first 10 days. The concentrations of DU in the organs in the G2-4 were observed. Abnormal values in blood examination were observed in G1-4, and BUN and creatinine were elevated. \n The results indicated that the lethal dose of DU by intramuscular injection was toxic over 7.9 mg/kg, and the DU retained rapidly in the kidneys, a target organ, and did not excreted after 2 days. CBMIDA and EHBP were effective to increase survival rates by removing DU in the kidneys and other organs.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "7th International Symposium on Chelating Agents in Biomedicine Toxicology and Therapeutics", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fukuda, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "600469", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iida, Haruzo"}], "nameIdentifiers": [{"nameIdentifier": "600470", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yan, Xueming"}], "nameIdentifiers": [{"nameIdentifier": "600471", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Xie, Yuyuan"}], "nameIdentifiers": [{"nameIdentifier": "600472", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "福田 俊", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "600473", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "飯田 治三", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "600474", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "厳 雪銘", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "600475", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Toxicities and Effects of CBMIDA and EHBP on Removal of Intramuscularly Injected Depleted Uranium in Rats", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Toxicities and Effects of CBMIDA and EHBP on Removal of Intramuscularly Injected Depleted Uranium in Rats"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/60486", "pubdate": {"attribute_name": "公開日", "attribute_value": "2004-07-20"}, "publish_date": "2004-07-20", "publish_status": "0", "recid": "60486", "relation": {}, "relation_version_is_last": true, "title": ["Toxicities and Effects of CBMIDA and EHBP on Removal of Intramuscularly Injected Depleted Uranium in Rats"], "weko_shared_id": -1}
Toxicities and Effects of CBMIDA and EHBP on Removal of Intramuscularly Injected Depleted Uranium in Rats
https://repo.qst.go.jp/records/60486
https://repo.qst.go.jp/records/60486b39f1a29-a8d9-4862-a4ff-2bc1cba3ef56
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2004-07-20 | |||||
タイトル | ||||||
タイトル | Toxicities and Effects of CBMIDA and EHBP on Removal of Intramuscularly Injected Depleted Uranium in Rats | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Fukuda, Satoshi
× Fukuda, Satoshi× Iida, Haruzo× Yan, Xueming× Xie, Yuyuan× 福田 俊× 飯田 治三× 厳 雪銘 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The toxicities and effects of CBMIDA and EHBP on removal of depleted uranium (DU) by intramuscular injection in the femoral muscles as simulated wounds in rats were examined in Experiment I~III. Male rats, 8 weeks old, were used. Experiment I: Rats were injected intramuscularly with 7.9, 15,8, 31.5, 63 and 126mg/kg depleted uranium. All rats died from 3~7 days after injection. The concentrations of DU in the kidneys were 8.4-16.6% of injected doses (r=0.997). In the rats injected with 63, 126 mg/kg, the urinary excretion of DU was observed at first day, and the feces excretion was for 2 days, but did not observed at third day. Total amount of excreted DU for 3 days were 3.4 % and 4.9% of the injected doses. Experiment II: Rats were injected with 63 mg/kg DU, and then killed 1, 3, 6 and 24 hours to know the retention. The concentration of DU decreased rapidly in the serum, while increased in the kidneys and liver until 6 hours after injection, and continued to increase in the femur until 24 hours. Experiment III: Forty rats were injected intramuscularly with 2mg/kg DU, and divide into four groups; G1) non-treated, G2) 0.48mg/kg CBMIDA, G3) 0.24mg/kg CBMIDA, and G4) 10mg/kg EHBP. The chelating agents were administered intraperitoneally once everyday for 28 days. Rats died for firs 10 days in the G1~3, and for 14 days in the G4. The survival rates at the end of experiment were 20% in the G1, 40% in the G2, 80% in the G3 and 50% in the G4. The rapid decreases in body weights were observed for first 10 days. The concentrations of DU in the organs in the G2-4 were observed. Abnormal values in blood examination were observed in G1-4, and BUN and creatinine were elevated. The results indicated that the lethal dose of DU by intramuscular injection was toxic over 7.9 mg/kg, and the DU retained rapidly in the kidneys, a target organ, and did not excreted after 2 days. CBMIDA and EHBP were effective to increase survival rates by removing DU in the kidneys and other organs. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 7th International Symposium on Chelating Agents in Biomedicine Toxicology and Therapeutics | |||||
発表年月日 | ||||||
日付 | 2004-07-11 | |||||
日付タイプ | Issued |